Literature DB >> 19834288

Protective effects of isoliquiritigenin against methamphetamine-induced neurotoxicity in mice.

Min Jung Lee1, Chae Ha Yang, Jae-Pil Jeon, Meeyul Hwang.   

Abstract

Isoliquiritigenin (ISL) suppresses cocaine-induced extracellular dopamine levels and has a neuroprotective effect in cocaine-treated rat brain. Here, we examine the effect of ISL on methamphetamine-induced striatal neurotoxicity. Repeated injections of methamphetamine cause the loss of striatal dopamine transporter (DAT) and tyrosine hydroxylase (TH). Intraperitoneal injection of ISL prior to methamphetamine injection significantly prevented methamphetamine-induced reduction of DAT and TH. ISL also suppressed methamphetamine-induced activation of glial cells. Moreover, ISL impeded the expression of nitric oxide synthase and the activation of NF-kappaB through blockage of its phosphorylation. Our results suggest that ISL protects against methamphetamine-induced neurotoxicity by inhibition of NF-kappaB activation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19834288     DOI: 10.1254/jphs.09153sc

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  7 in total

1.  Neuroprotective and anti-inflammatory effects of isoliquiritigenin in kainic acid-induced epileptic rats via the TLR4/MYD88 signaling pathway.

Authors:  Xiaobo Zhu; Jiankun Liu; Ou Chen; Jiang Xue; Shanying Huang; Weiwei Zhu; Yibiao Wang
Journal:  Inflammopharmacology       Date:  2019-04-29       Impact factor: 4.473

2.  Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways.

Authors:  Ji-Nan Dai; Yi Zong; Lian-Mei Zhong; Yue-Min Li; Wei Zhang; Li-Gong Bian; Qing-Long Ai; Yi-Dan Liu; Jun Sun; Di Lu
Journal:  PLoS One       Date:  2011-07-12       Impact factor: 3.240

3.  Blockade of nicotine sensitization by methanol extracts of Glycyrrhizae radix mediated via antagonism of accumbal oxidative stress.

Authors:  Zheng Lin Zhao; Sang Chan Kim; Hong Feng Liu; Yi Yan Wu; Li Bo Li; Yu Hua Wang; Yu Jiao; Yu Fan; Chul Won Lee; Bong Hyeo Lee; Il Je Cho; Chae Ha Yang; Rong Jie Zhao
Journal:  BMC Complement Altern Med       Date:  2017-11-16       Impact factor: 3.659

4.  Isoliquiritigenin alleviates early brain injury after experimental intracerebral hemorrhage via suppressing ROS- and/or NF-κB-mediated NLRP3 inflammasome activation by promoting Nrf2 antioxidant pathway.

Authors:  Jun Zeng; Yizhao Chen; Rui Ding; Liang Feng; Zhenghao Fu; Shuo Yang; Xinqing Deng; Zhichong Xie; Shizhong Zheng
Journal:  J Neuroinflammation       Date:  2017-06-13       Impact factor: 8.322

5.  Natural Polyhydroxy Flavonoids, Curcuminoids, and Synthetic Curcumin Analogs as α7 nAChRs Positive Allosteric Modulators.

Authors:  Marta Ximenis; José Mulet; Salvador Sala; Francisco Sala; Manuel Criado; Rosario González-Muñiz; María Jesús Pérez de Vega
Journal:  Int J Mol Sci       Date:  2021-01-19       Impact factor: 5.923

6.  Isoliquiritigenin attenuates lipopolysaccharide-induced cognitive impairment through antioxidant and anti-inflammatory activity.

Authors:  Xiaobo Zhu; Jiankun Liu; Shaojie Chen; Jiang Xue; Shanying Huang; Yibiao Wang; Ou Chen
Journal:  BMC Neurosci       Date:  2019-08-06       Impact factor: 3.288

7.  Isoliquiritigenin, a potent human monoamine oxidase inhibitor, modulates dopamine D1, D3, and vasopressin V1A receptors.

Authors:  Ritu Prajapati; Su Hui Seong; Se Eun Park; Pradeep Paudel; Hyun Ah Jung; Jae Sue Choi
Journal:  Sci Rep       Date:  2021-12-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.